{
    "id": 713,
    "name": "HCL-V",
    "source": "DOID",
    "definition": null,
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:713",
    "evidence": [
        
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT03805932",
            "title": "Title: Moxetumomab Pasudotox-tdfk (Lumoxiti ) and Rituximab (Rituxan ) for Relapsed Hairy Cell Leukemia",
            "phase": "Phase I",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 8673,
                    "therapyName": "Moxetumomab pasudotox-tdfk + Rituximab",
                    "synonyms": null
                }
            ]
        }
    ]
}